Study on Plasma Exchange vs. Daratumumab for Light Chain Cast Nephropathy
A clinical trial is underway to evaluate the effectiveness of plasma exchange compared to daratumumab-based and non-daratumumab-based regimens in improving renal outcomes for patients with light chain cast nephropathy.